Langdon & Emison Accepting Talcum Powder Cases

Langdon & Emison is reviewing potential lawsuits on behalf of women who developed ovarian cancer after using talcum powder on a daily or weekly basis during a four-year period or longer.

Two recent lawsuits against Johnson & Johnson yielded $72 million and $55 million verdicts, respectively in favor of plaintiffs who developed ovarian cancer after using the company’s Baby Powder and Shower to Shower products for 35 years or more.

Talc is a moisture-absorbing mineral widely used in cosmetics and personal care products such as talcum powder. At least 23 medical studies conducted as early as 1971 have linked talc to ovarian cancer; in 2006, the World Health Organization classified genital talc as a carcinogen.

Despite knowing about the studies, Johnson & Johnson worked to hide the results from the public and instead distributed misleading information to deceive the public, according to more than 1,000 lawsuits filed nationally.

St. Louis juries in two separate trials found against J&J counts, including negligence, conspiracy and failure to warn consumers about the link between talc and cancer.

Talc was originally implicated as a possible ovarian carcinogen because of its chemical similarity to asbestos, which has been linked to ovarian cancer in occupational settings and is associated with mesothelioma.

The American Cancer Society contends there is a 30 to 40 percent increased risk of ovarian cancer associated with regular talc use.

Contact Langdon & Emison

If you or a loved one developed ovarian cancer as a result of talcum powder use, contact Langdon & Emison for a free case evaluation at 800-397-4910.